Prof. Dr. Yasuhisa Fujibayashi, National Institute of Radiological Sciences, School of Medicine, Keio University, Japan

Making hypoxic metabolism visible for 64Cu-ATSM treatment using simultaneous PET/SPECT imaging

PET, SPECT

Exploit simultaneous 99mTc-HSA/64Cu-ATSM imaging to accelerate the development of 64Cu-ATSM as an add-on targeted radiotherapy agent.

February 2021

Related webinars

Synergetic Photon Tomography from 1eV to 1MeV: Integrated Ultra-high Definition PET, SPECT, X-ray and Optical CT
Synergetic Photon Tomography from 1eV to 1MeV: Integrated Ultra-high Definition PET, SPECT, X-ray and Optical CT
In vivo molecular imaging for the preclinical development and validation of radiopharmaceuticals
In vivo molecular imaging for the preclinical development and validation of radiopharmaceuticals
No results found.
Share this webinar

Want to know what MILabs can do for you?